FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

Action Advances Fight Against COVID-19, Follows Comprehensive Evaluation of Available Safety, Effectiveness and Manufacturing Quality Information by FDA Career Scientists, Input from External Experts Today, the U.S. Food and Drug Administration issued an emergency use...
Semaglutide for Weight Loss? A Good First STEP, With Caveats

Semaglutide for Weight Loss? A Good First STEP, With Caveats

The phase 3a STEP 1 trial that investigated the use of semaglutide (Novo Nordisk), a glucagon-like peptide-1 (GLP-1) agonist, for weight loss is aptly named, some say. “In sum, we have a long way to go to control the obesity epidemic…but on the face of it,...
Lower Back Pain: NSAID + Muscle Relaxant No Better Than NSAID + Placebo

Add-On Atypicals for Depression Carry ‘Substantial’ Death Risk

“Our study in nonelderly adults with depression did not identify a single predominant cause of death. However, this may be a result of both the relatively small number of deaths in our study as well as of the well-recognized concerns regarding the accuracy of...

Pin It on Pinterest